
Neocardio Diagnostics Llp
Design, manufacture, import, export, buy, sell, install, market nutraceuticals and diagnostic products.
Design, manufacture, import, export, buy, sell, install, market nutraceuticals and diagnostic products.
Chennai, Tamil Nadu, India
+91-XXXXXXXXXX
AAS-4657
22 May 2020
31 Mar 2021
Roc-Chennai
Limited Liability Partnership
Name | Designation | Appointment Date | Status |
---|---|---|---|
Karthik Reddy ![]() | Designated Partner | 22-May-2020 | Current |
Sankaranarayanan Krishnan ![]() | Designated Partner | 22-May-2020 | Current |
Enhance accessibility to Neocardio Diagnostics Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Neocardio Diagnostics Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Sankaranarayanan Krishnan is a mutual person
Karthik Reddy is a mutual person
Karthik Reddy is a mutual person
Karthik Reddy is a mutual person
Karthik Reddy is a mutual person
Sankaranarayanan Krishnan is a mutual person
There are no Open Charges registered against the LLP as per our records.
Unlock and access historical data on people associated with Neocardio Diagnostics Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neocardio Diagnostics Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neocardio Diagnostics Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Neocardio Diagnostics Llp has filed its annual Financial statements for the year ended 31 Mar 2021 with RoC-Chennai.
Karthik Anand Reddy was appointed as a Designated Partner was appointed as a Designated Partner on 22 May 2020 & has been associated with this company since 4 years 10 months .
Sankaranarayanan Muthu Krishnan was appointed as a Designated Partner was appointed as a Designated Partner on 22 May 2020 & has been associated with this company since 4 years 10 months .
Neocardio Diagnostics Llp was registered on 22 May 2020 with RoC-Chennai & aged 4 years 10 months as per MCA records.
Neocardio Diagnostics Llp was incorporated on 22 May 2020.
The Obligation of Contribution of Neocardio Diagnostics Llp is ₹ 1.75 Cr.
Currently 2 partners are associated with Neocardio Diagnostics Llp.
As per Ministry of Corporate Affairs (Mca), the registered address of Neocardio Diagnostics Llp is 3Rd Floor Jhaver Plaza 1A, Nungambakkam High Road, Chennai, Tamil Nadu, India, 600034.
The Limited Liability Partnership Identification Number (LLPIN) of Neocardio Diagnostics Llp is AAS-4657.
The most recent Balance Sheet for Neocardio Diagnostics Llp was filed with the ROC on 31 Mar 2021.